PerkinElmer (PKI) News Headlines

▮ More

Date

Headline

7/28/2020 4:31:09 PM PerkinElmer Q2 adjusted earnings Beat Estimates

7/28/2020 4:19:53 PM PerkinElmer Q2 EPS $1.23 Vs. $0.62 Year Ago

7/28/2020 3:00:35 PM PerkinElmer Q2 20 Earnings Conference Call 5:00 PM ET

7/23/2020 4:24:27 PM PerkinElmer Declares Quarterly Dividend Of $0.07/share, Payable Nov. 6/ Record Oct. 16

7/23/2020 4:23:07 PM PerkinElmer (PKI) Declares Quarterly Dividend of $ 0.07, Record Date 10/16/2020

7/21/2020 8:06:28 AM PerkinElmer Announces The Launch Of Dry Blood Spot Based Test For SARS-CoV-2 IgG

7/21/2020 8:04:15 AM PerkinElmer Announces Launch Of A Dry Blood Spot Based Test For SARS-CoV-2 IgG

7/13/2020 8:12:52 AM PerkinElmer Projects Approx. 12% Growth In Q2 Revenue - Quick Facts

7/13/2020 8:04:19 AM PerkinElmer Anticipates Growth In Both Reported Revenue And Organic Revenue Of 12% For Q2

6/4/2020 8:00:08 AM PerkinElmer To Present At Jefferies Global Healthcare Conference; Webcast At 9:00 AM ET

5/18/2020 10:04:51 AM PerkinElmer Says US Investigation Does N't Target Company Or Its Personnel

5/18/2020 9:31:23 AM PerkinElmer Receives Subpoenas From Government Regarding investigations Into Third Parties

5/5/2020 4:33:48 PM PerkinElmer Q1 adjusted earnings Beat Estimates

5/5/2020 4:19:02 PM PerkinElmer Q1 EPS $0.30 Vs. $0.32 Year Ago

5/5/2020 3:01:42 PM PerkinElmer Q1 20 Earnings Conference Call At 5:00 PM ET

5/5/2020 9:39:58 AM PKI Gets FDA Emergency Nod For Serological Test To Identify COVID-19 Antibodies

5/5/2020 9:19:18 AM PerkinElmer : FDA Provides Emergency Use Authorization To Serological Test To Identify COVID-19 Antibodies

4/30/2020 4:18:20 PM PerkinElmer (PKI) Declares Quarterly Dividend of $ 0.07, Record Date 7/17/2020

3/9/2020 6:31:28 AM PerkinElmer Sees Q1 Results Below Prior Guidance On COVID 19 Impact

3/9/2020 6:03:51 AM PerkinElmer Expects Q1 Revenue And EPS To Be Below Prior Guidance

Perkinelmer (PKI)